Epilepsy Society welcomes Twitter’s ban of GIF search terms
Twitter have taken the decision to ban three key search terms, ‘epileptic, photosensitive and photosensitivity’ from its GIF search function, after internet trolls persistently used them to access flashing images with the intent of triggering seizures in people with epilepsy.
Women still unaware of risks around epilepsy medicines in pregnancy – charity survey finds
PLEASE NOTE: Women and girls should not stop taking valproate without first discussing it with their doctor. Up-to-date information and guidance on valproate use can be found here.
Cumberlege Review slams way healthcare system has responded to families affected by sodium valproate
After a two-year review led by Baroness Cumberlege, right, the Independent Medicines and Medical Devices Safety Review has today published its report into three medical interventions: the epilepsy medication, sodium valproate; the hormone pregnancy test, Primodos; and pelvic mesh implants.
Clare Pelham highlights need for radical change in regulation of healthcare system
Following the publication of the Independent Medicines and Medical Devices Safety Review, Clare Pelham, Chief Executive at the Epilepsy Society, says the appointment of a Patient Safety Commissioner and radical change at the regulatory body, the MHRA, are top priorities.
Hero Zach completes his 2.6 challenge
This was the joyful moment when nine-year-old Zach Eagling crossed the finishing line to complete his #twopointsix challenge, raising a staggering £11,500 for the Epilepsy Society.
Vimpat 50mg X 14 tablets shortage expected
We have been informed by UCB that Vimpat (lacosamide) 50mg x 14 tablets are likely to be out of stock within the next three weeks. The shortage is expected to last for a two-three week period.